Test List for BioTrinity

Test List for BioTrinity Preliminary Showcase Announced at BioTrinity 2009 - Features the Most Promising Emerging Companies

2008-12-01T17:41:10Z

I'm really pleased to be able to tell you that we've assembled a fantastic preliminary line-up at BioTrinity 2009, well in advance of what promises to be the UK's Premier Biotech and Investment Conference.

A brief look at the preliminary line up of the first 20+ companies selected for corporate presentations at the upcoming BioTrinity 2009 conference (April 2-3, Oxford), tells the exciting story of some of the most successful emerging and growing biotech and medtech companies in the world - some raising money in 2008. No wonder that registration for 2009 is running 3-fold higher than last year!

Vantia Therapeutics, which raised �19m earlier this year as it spun-out of Ferring Pharma ... more...

AdaptImmune, which hit the headlines with its engineered HIV killer T-cells 2 weeks ago ... more...

Circassia, which raised �11m in its oversubscribed round earlier this year, for immune control technologies ... more...

Apitope, which recently raised EUR 10m in a novel series A financing, to develop MS, diabetes and Factor VIII resistance treatments and diagnostics ... more...

Oxford BioMedica which has promising results with its ProSavin treatment for Parkinsons in phase I/II ... more...

Take a look at the Company Showcase line-up as it begins to develop.

If your R&D company wishes to be considered for selection for one of the few remaining presentation slots, please make an online application or contact Jon Rees directly on +44(0)1865594642

Remember: You have just 10 days left to take advantage of the Early Bird registration offer.

New for 2009:

Invitation�only Investor Dinner
Pre-conference champagne reception and Gala Dinner at Oxford colleges
Investment/corporate presentations
by biotech and medtech companies
Dedicated investment and partnering booths
Expanded networking space

Facts from 2008:

500+ one-to-one partnering meetings
400+ delegates
270 companies
12 countries represented

Companies Confirmed for 2009:

Shire Pharma Oxford BioMedica Merck AdaptImmune Eli Lilly Solvias AG Genzyme PharmaTV Bristol Myers-Squibb Intertek (OSI) Prosidion Oxygen Healthcare EUSA Pharma BBSRC Atlas Venture Domainex Takeda Research Investment Inc Hybrid Systems Novo Ventures Innovator Capital MP Healthcare Venture Management Oxford Capital Partners Vantia Therapeutics UniTech Pharma Immunocore Cytox Group Cellzome Eykona Technologies Oxford Gene Technology Plant Vaccines Limited Circassia Alchemy Healthcare GlycoForm Oxford Expression Technologies Glide Pharma Epistem Inhibox Capsant Neurotechnologies Orthox Giles Insurance Apitope Simbec Research Particle Therapeutics Regulatory Resources Group De Facto AbD Serotec Manches Netherlands Foreign Investment Agency MEPC Milton Park UKTI Drug Discovery Today OBN VirdisPharma Interea International EBD Group EAPD Innovations Frank B Dehn TVLSN James Cowper Lab Support UK Ltd PULSE Scientific FOCUS Insurance Fry Heath Spence Oxford Science Park Mewburn Ellis LLP Riverbank IT Teva Pharmaceutical Industries

Click to View the 2008 Gallery

WHO SHOULD ATTEND?

Biotech & MedTech Executives

8 minute presentation opportunity to pharma and investor audience
Panel discussions for emerging biotechs on finance and key issues
Private 1-to-1 partnering rooms and booths

Mid & Large Pharma Executives

Access to Company presentations (Biotech and Medtech)
Private 1-to-1 partnering rooms and booths
Opportunity for dedicated partnering rooms

Investors

Invitation-only investor dinner
Wide range of investment opportunities
Private 1-to-1 partnering rooms
Opportunity for dedicated partnering rooms

Registration Fees

OBN Member companies can take advantage of the lower rate of �399 + VAT, including a complimentary ticket with the first person registering from within Full Member companies. Do consider registering early to ensure your partnering profile is available when partnering begins on February 17th 2009, before New Year's schedule kicks in.

Are you ready to join the 300+ companies expected at BioTrinity 2009?

Early Bird Registration Fee (until Dec 15, 2008)

Special Registration Fee (until Feb 14, 2009)

Registration Fee (until April 1, 2009)

On-site Registration Fee

�499 + VAT

�549 + VAT

�599 + VAT

�650 + VAT

Test List for BioTrinity Preliminary Showcase Announced at BioTrinity 2009 - Features the Most Promising Emerging Companies

2008-12-01T17:35:36Z